Indian pharma

India Supplies 20% of Global Generic Medicines, GTRI Confirms IP Rules WTO-Compliant

Post published:May 24, 2026
Post category:News

New Delhi, May 2026 — India now supplies nearly 20% of the world’s generic medicines, according to a comprehensive report from the Global Trade Research Initiative (GTRI). The report, released…

India’s Generic Drug Resilience: 20% Global Market Share, US Tariff Exemption, and the Semaglutide Revolution

Post published:May 22, 2026
Post category:News

India's pharmaceutical industry continues to demonstrate remarkable resilience and global influence in 2026. With the nation supplying approximately 20% of the world's generic medicines, recent developments — including US tariff…

WHO Adds GLP-1 Drugs and New Cancer Treatments to Essential Medicines List in 2025 Update

Post published:May 18, 2026
Post category:Knowledge

The World Health Organization (WHO) has updated its Essential Medicines List (EML) in September 2025, adding several landmark drugs including GLP-1 receptor agonists for diabetes and obesity, new cancer treatments,…